ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
2.
ChangAStaugaitisSMDuttaR, et al. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann Neurol2012; 72(6): 918–926.
3.
FilippiMBrückWChardD, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol2019; 18(2): 198–210.
4.
GlasserMFVan EssenDC. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci2011; 31(32): 11597–11616.
5.
BeckESSatiPSethiV, et al. Improved visualization of cortical lesions in multiple sclerosis using 7T MP2RAGE. AJNR Am J Neuroradiol2018; 39(3): 459–466.
6.
SchmiererKParkesHGSoPW, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain2010; 133(Pt 3): 858–867.
7.
NakamuraKChenJTOntanedaD, et al. T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis. Ann Neurol2017; 82(4): 635–639.
8.
PreziosaPBoumanPMKiljanS, et al. Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis. J Neurol Neurosurg Psychiatry2021; 92: 790–792.
9.
RighartRBiberacherVJonkmanLE, et al. Cortical pathology in multiple sclerosis detected by the T 1/T 2-weighted ratio from routine magnetic resonance imaging. Ann Neurol2017; 82(4): 519–529.
10.
ZhengYDudmanJChenJT, et al. Sensitivity of T1/T2-weighted ratio in detection of cortical demyelination is similar to magnetization transfer ratio using post-mortem MRI. Mult Scler. Epub ahead of 20May2021. DOI: 10.1177/13524585211014760.
